• 1
    Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 1998; 338: 1397404.
  • 2
    Padma-nathan H, Eardley I, Kloner RA, Laties AM, Montorsi FA. 4-year update on the safety of sildenafil citrate (Viagra). Urology 2002; 60 (Suppl. 2): 6790.
  • 3
    Christiansen E, Guirguis WR, Cox D, Osterloh IH. Sildenafil Multicentre Study Group. Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal. Int. J. Impot. Res. 2000; 12: 17782.
  • 4
    Montorsi F, Salonia A, Briganti A et al. Vardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experience. Eur. Urol. 2005; 47: 61221.
  • 5
    Hatzichristou D, Vardi Y, Papp G, Pushkar D, Basson BR, Kopernicky V. Effect of tadalafil on sexual timing behavior patterns in men with erectile dysfunction: integrated analysis of randomized, placebo controlled trials. J. Urol. 2005; 174: 13569.
  • 6
    Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S. Development and validation of the Self-Esteem and Relationship (SEAR) questionnaire in erectile dysfunction. Int. J. Impot. Res. 2004; 16: 308.
  • 7
    Saenz de Tejada I, Angulo J, Cellek S et al. Physiology of erectile function and pathophysiology of erectile dysfunction. In: LueTF, BassonR, RosenR, GiulianoF, KhouryS, MontorsiF (eds). Sexual Medicine: Sexual Dysfunctions in Men and Women. Editions 21, Paris, 2004; 287343.
  • 8
    Klotz T, Mathers M, Klotz R, Sommer F. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)? Int. J. Impot. Res. 2005; 17: 24.
  • 9
    Hatzichristou D, Moysidis K, Apostolidis A et al. Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. Eur. Urol. 2005; 47: 51822.
  • 10
    Souverein PC, Egberts AC, Meuleman EJ, Urquhart J, Leufkens HG. Incidence and determinants of sildenafil (dis) continuation: the Dutch cohort of sildenafil users. Int. J. Impot. Res. 2002; 14: 25965.
  • 11
    Althof SE. When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int. J. Impot. Res. 2002; 14 (Suppl. 1): S99104.
  • 12
    McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology 2002; 60 ( 2 Suppl. 2): 2838.
  • 13
    Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 1999; 11: 31926.
  • 14
    Lue TF, Basson R, Rosen R. Summary of the recommendations on sexual dysfunction in men. In: LueTF, BassonR, RosenR, GiulianoF, KhouryS, MontorsiF (eds). Sexual Medicine: Sexual Dysfunctions in Men and Women. Editions 21, Paris, 2004; 60527.
  • 15
    Atiemo HO, Szostak MJ, Sklar GN. Salvage of sildenafil failures referred from primary care physicians. J. Urol. 2003; 170: 23568.